AU4778297A - Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same - Google Patents

Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same

Info

Publication number
AU4778297A
AU4778297A AU47782/97A AU4778297A AU4778297A AU 4778297 A AU4778297 A AU 4778297A AU 47782/97 A AU47782/97 A AU 47782/97A AU 4778297 A AU4778297 A AU 4778297A AU 4778297 A AU4778297 A AU 4778297A
Authority
AU
Australia
Prior art keywords
preparation
producing
same
uremic syndrome
hemolytic uremic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47782/97A
Inventor
Alfred Arnold
Hans-Iko Huppertz
Helge Karch
Reinhard Lissner
Wolfgang Moller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Pharma GmbH
Original Assignee
Biotest Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Pharma GmbH filed Critical Biotest Pharma GmbH
Publication of AU4778297A publication Critical patent/AU4778297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to the use of immunoglobulin preparations with high antibody content against EHEC hemolysin and optionally against surface antigens of EHEC hemolysin gene carrying bacteria and against shiga-like toxin II for producing an oral medicament to prevent hemolytic uremic syndrome after EHEC infection and a preparation for the same. The high antibody content can be obtained by a targeted selection of individual donors or by the immunization of donor animals.
AU47782/97A 1996-10-09 1997-09-25 Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same Abandoned AU4778297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19641466 1996-10-09
DE19641466A DE19641466A1 (en) 1996-10-09 1996-10-09 Oral use of an immunoglobulin preparation for the prevention of hemolytic uremic syndrome and a preparation therefor
PCT/EP1997/005262 WO1998015578A1 (en) 1996-10-09 1997-09-25 Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same

Publications (1)

Publication Number Publication Date
AU4778297A true AU4778297A (en) 1998-05-05

Family

ID=7808174

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47782/97A Abandoned AU4778297A (en) 1996-10-09 1997-09-25 Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same

Country Status (7)

Country Link
EP (1) EP0941251B1 (en)
JP (1) JP2001502309A (en)
AT (1) ATE223437T1 (en)
AU (1) AU4778297A (en)
DE (2) DE19641466A1 (en)
ES (1) ES2183144T3 (en)
WO (1) WO1998015578A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10298105A (en) * 1997-04-23 1998-11-10 Gen Corp:Kk Preventing and curing agent for infectious disease caused by enterohemorrhagic escherichia coli
US7846435B1 (en) 1998-05-20 2010-12-07 Teijin Limited Humanized antibodies that recognize Verotoxin II and cell line producing same
US9579370B2 (en) 2014-03-04 2017-02-28 The Board Of Regents Of The University Of Texas System Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination
US10226520B2 (en) 2014-03-04 2019-03-12 The Board Of Regents Of The University Of Texa System Compositions and methods for enterohemorrhagic Escherichia coli (EHEC) vaccination

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836349B (en) * 1982-09-02 1985-04-24 Unilever Plc Production of antibodies
DE58904683D1 (en) * 1988-04-19 1993-07-22 Biotest Pharma Gmbh PREPARATION WITH ANTI-CORE PERACTIVITY AND WIDE RANGE OF EFFECTS, SUBSTANCES CONTAINING OR CONTAINING THEM AND THE USE THEREOF FOR THE TREATMENT OF BACTERIAL OR TOXINE-RELATED DISEASES AND FOR THE POTENTIAL OF PROTECTION.
WO1995008562A1 (en) * 1993-09-20 1995-03-30 Anadis Ltd. Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
AUPN642795A0 (en) * 1995-11-08 1995-11-30 Northfield Laboratories Pty Ltd Dairy compositions and methods of preparing same

Also Published As

Publication number Publication date
ATE223437T1 (en) 2002-09-15
EP0941251B1 (en) 2002-09-04
EP0941251A1 (en) 1999-09-15
JP2001502309A (en) 2001-02-20
WO1998015578A1 (en) 1998-04-16
ES2183144T3 (en) 2003-03-16
DE19641466A1 (en) 1998-04-16
DE59708140D1 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
MD970199A (en) Induction of a cytotoxic T-lymphocytic answer The invention relates to the medicine, particularly to the immunology and can be used for treatment of bacterial and parasitic infections, tumors and other diseases. The summary of the invention consists in the induction of a cytotoxic T-lymphocytic answer to human and animals by means of a composition consisting of an antigene and an antigenic formulati
AU1915995A (en) Active immunization using a siderophore receptor protein
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
MX9203832A (en) USE OF LIPASES FOR THE PREPARATION OF MEDICINES
IL128014A0 (en) Method of producing active immunity with vaccine conjugate
CA2145397A1 (en) Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
NZ309713A (en) Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine
EP0041897A3 (en) Polysaccharide antigen from streptococcus and vaccine containing the same
DK341679A (en) VACCINE AGAINST DRAFT COOKIES AND PROCEDURES FOR PRODUCING THEREOF
CA2123222A1 (en) Gram-negative bacterial vaccines
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
IE940698L (en) Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
AU4778297A (en) Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same
EP0694309A3 (en) Vaccine, antigens and antibodies containing compound for inhibiting and preventing induced staphylococcus infection
GEP20002257B (en) Method for Reducing Fibrin Accumulation Speed, Prophylactics of Thrombus Complications and Treatment of Blood Vessels Diseases, Medicinal Composition and Medicinal Species
Andron LA et al. Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis
EP0836480A4 (en) Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
Kurono et al. Effects of oral and systemic immunization on nasopharyngeal clearance of nontypeable Haemophilus influenzae in BALB/c mice
CA2128247A1 (en) Vaccines based on streptokinase
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
AU1796492A (en) Antigen recognized by antibodies associated with paraneoplastic opsoclonus and methods of use thereof
AU5523196A (en) Methods and compositions for production of customized vaccines for diseases associated with antigens of microorganisms
AU6596390A (en) Monoclonal antibodies cross-reactive and cross-protective against p. aeruginosa serotypes
Watanabe et al. Serological analysis of supernatant liquids of cultures of El Tor vibrios
EP0368466A3 (en) Compositions and methods for the treatment and prevention of gram-negative bacterial infections